{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:22:11Z","timestamp":1792624931066,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children\u2019s Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21-AI103480"],"award-info":[{"award-number":["R21-AI103480"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI100114"],"award-info":[{"award-number":["R01 AI100114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.05.085","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T02:30:40Z","timestamp":1496889040000},"page":"3834-3843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Ledue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Herd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.085_b0005","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.05.085_b0010","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.vaccine.2017.05.085_b0015","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.085_b0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","article-title":"The role of nasal carriage in Staphylococcus aureus infections","volume":"5","author":"Wertheim","year":"2005","journal-title":"Lancet Inf Dis"},{"key":"10.1016\/j.vaccine.2017.05.085_b0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2017.05.085_b0030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4161\/hv.34414","article-title":"Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study","volume":"11","author":"Fattom","year":"2015","journal-title":"Human vaccines & immunotherapeutics."},{"key":"10.1016\/j.vaccine.2017.05.085_b0035","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/AAC.00570-07","article-title":"Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia","volume":"51","author":"Rupp","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2017.05.085_b0040","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial","volume":"309","author":"Fowler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.05.085_b0045","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2013.04.002","article-title":"Vaccine review: Staphyloccocus aureus vaccines: problems and prospects","volume":"31","author":"Jansen","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.085_b0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2007.04.060","article-title":"Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants","volume":"151","author":"DeJonge","year":"2007","journal-title":"J Pediatr."},{"key":"10.1016\/j.vaccine.2017.05.085_b0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.2010-3081","article-title":"A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis","volume":"128","author":"Weisman","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.05.085_b0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/apc.2008.0240","article-title":"Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.vaccine.2017.05.085_b0065","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.05.085_b0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.05.085_b0075","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI40891","article-title":"IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice","volume":"120","author":"Cho","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.05.085_b0080","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1128\/IAI.00084-13","article-title":"Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx","volume":"81","author":"Archer","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4161\/hv.18946","article-title":"Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17\/IL17 pathway in a murine sepsis model","volume":"8","author":"Joshi","year":"2012","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.05.085_b0090","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1128\/IAI.00447-10","article-title":"Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A","volume":"78","author":"Narita","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0095","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/IAI.00700-08","article-title":"The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus","volume":"76","author":"Spellberg","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0100","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1128\/IAI.01491-14","article-title":"Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A","volume":"82","author":"Montgomery","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0105","doi-asserted-by":"crossref","first-page":"e0136021","DOI":"10.1371\/journal.pone.0136021","article-title":"Active immunization with extracellular vesicles derived from Staphylococcus aureus effectively protects against staphylococcal lung infections, mainly via Th1 cell-mediated immunity","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.085_b0110","doi-asserted-by":"crossref","first-page":"e1005226","DOI":"10.1371\/journal.ppat.1005226","article-title":"Memory Th1 cells are protective in invasive Staphylococcus aureus infection","volume":"11","author":"Brown","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.05.085_b0115","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20142101","article-title":"Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection","volume":"212","author":"Glennie","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.05.085_b0120","first-page":"1899","article-title":"Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice","volume":"119","author":"Zhang","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.05.085_b0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.05.085_b0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00109-009-0579-4","article-title":"Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development","volume":"88","author":"Malley","year":"2010","journal-title":"J Mol Med"},{"key":"10.1016\/j.vaccine.2017.05.085_b0135","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.05.085_b0140","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1128\/IAI.55.12.3030-3034.1987","article-title":"Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits","volume":"55","author":"Greenberg","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/2049-632X.12042","article-title":"Irradiated wild-type and Spa mutant Staphylococcus aureus induce anti-S. aureus immune responses in mice which do not protect against subsequent intravenous challenge","volume":"68","author":"van Diemen","year":"2013","journal-title":"Pathogens Dis"},{"key":"10.1016\/j.vaccine.2017.05.085_b0150","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/infdis\/jis579","article-title":"Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection","volume":"206","author":"Burnside","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.085_b0155","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1096\/fj.11-187963","article-title":"Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses","volume":"25","author":"Kim","year":"2011","journal-title":"FASEB J: Off Pub Fed Am Soc Exp Biol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.rvsc.2013.10.004","article-title":"Immune response of heifers against a Staphylococcus aureus CP5 whole cell and lysate vaccine formulated with ISCOM Matrix adjuvant","volume":"96","author":"Camussone","year":"2014","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2017.05.085_b0165","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3168\/jds.S0022-0302(01)74617-6","article-title":"Immunization with Staphylococcus aureus lysate incorporated into microspheres","volume":"84","author":"O'Brien","year":"2001","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.vaccine.2017.05.085_b0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0002-9394(14)72016-1","article-title":"The effect of Staphylococcus aureus phage lysate vaccine on a rabbit model of staphylococcal blepharitis, phlyctenulosis, and catarrhal infiltrates","volume":"122","author":"Giese","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2180-7-99","article-title":"Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus","volume":"7","author":"Highlander","year":"2007","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0180","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.vaccine.2012.03.039","article-title":"A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi","volume":"30","author":"Lu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.085_b0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CVI.00036-10","article-title":"Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine","volume":"17","author":"Lu","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0190","doi-asserted-by":"crossref","first-page":"e5190","DOI":"10.1371\/journal.pone.0005190","article-title":"Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens","volume":"4","author":"Lee","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.085_b0195","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/mi.2014.111","article-title":"Cholera toxin adjuvant promotes a balanced Th1\/Th2\/Th17 response independently of IL-12 and IL-17 by acting on Gsalpha in CD11b(+) DCs","volume":"8","author":"Mattsson","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jim.2014.04.007","article-title":"Mouse models for infectious diseases caused by Staphylococcus aureus","volume":"410","author":"Kim","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2017.05.085_b0205","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.1523-1747.2000.00973.x","article-title":"An experimental model of cutaneous infection induced by superantigen-producing Staphylococcus aureus","volume":"114","author":"Molne","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0210","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/IAI.71.5.2716-2723.2003","article-title":"Strain-specific association of cytotoxic activity and virulence of clinical Staphylococcus aureus isolates","volume":"71","author":"Krut","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0215","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/infdis\/jis463","article-title":"Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice","volume":"206","author":"Mishra","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.085_b0220","doi-asserted-by":"crossref","first-page":"e1002307","DOI":"10.1371\/journal.ppat.1002307","article-title":"Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood","volume":"7","author":"McAdow","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.05.085_b0225","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1073\/pnas.1424924112","article-title":"Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.05.085_b0230","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.4049\/jimmunol.1401633","article-title":"Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling","volume":"194","author":"Larena","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0235","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/IAI.69.8.4870-4873.2001","article-title":"Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci","volume":"69","author":"Malley","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0240","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1016\/j.vaccine.2010.09.031","article-title":"GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis","volume":"28","author":"Lu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.085_b0245","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.05.085_b0250","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/mi.2012.39","article-title":"IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques","volume":"5","author":"Xu","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.1202924","article-title":"Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection","volume":"190","author":"Gladiator","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00281-011-0293-5","article-title":"Development of a vaccine against Staphylococcus aureus","volume":"34","author":"Spellberg","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0265","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/cid\/cis033","article-title":"Challenges for a universal Staphylococcus aureus vaccine","volume":"54","author":"Proctor","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.085_b0270","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.vaccine.2011.11.006","article-title":"Is there a future for a Staphylococcus aureus vaccine?","volume":"30","author":"Proctor","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.085_b0275","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/cir828","article-title":"Progress toward a Staphylococcus aureus vaccine","volume":"54","author":"Daum","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.085_b0280","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1084\/jem.116.5.601","article-title":"Factors relating to the virulence of Staphylococci. III. Antibacterial versus antioxic immunity","volume":"116","author":"Koenig","year":"1962","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.05.085_b0285","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0022029907002476","article-title":"Characterization of the antibody isotype response in serum and milk of heifers vaccinated with a Staphylococcus aureus bacterin (Lysigin)","volume":"74","author":"Luby","year":"2007","journal-title":"J Dairy Res"},{"key":"10.1016\/j.vaccine.2017.05.085_b0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S0022029905001354","article-title":"Efficacy of different Lysigin formulations in the prevention of Staphylococcus aureus intramammary infection in dairy heifers","volume":"73","author":"Middleton","year":"2006","journal-title":"J Dairy Res"},{"key":"10.1016\/j.vaccine.2017.05.085_b0295","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1128\/IAI.01632-13","article-title":"Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins","volume":"82","author":"Moffitt","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.085_b0300","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.vaccine.2012.01.034","article-title":"Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine","volume":"30","author":"Moffitt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.085_b0305","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1073\/pnas.1121383109","article-title":"Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity","volume":"109","author":"Malley","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.05.085_b0310","doi-asserted-by":"crossref","first-page":"e43445","DOI":"10.1371\/journal.pone.0043445","article-title":"Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine","volume":"7","author":"Moffitt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.085_b0315","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2958.2002.02935.x","article-title":"Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A","volume":"44","author":"O'Brien","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0320","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2958.1995.tb02316.x","article-title":"Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus","volume":"16","author":"McDevitt","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.085_b0325","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.coi.2011.04.002","article-title":"Next generation pneumococcal vaccines","volume":"23","author":"Moffitt","year":"2011","journal-title":"Curr Opin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T18:44:53Z","timestamp":1602269093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":65,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17307533"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}